Simplex Trading’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Simplex Trading’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-405	Closed	-$15K	–	11414
2022 Q1	$15K	Buy	+405	New	+$14K	﹤0.01%	8557
2021 Q4	–	Sell	-170	Closed	-$16K	–	11697
2021 Q3	$16K	Hold	170	–	–	﹤0.01%	8634
2021 Q2	$16K	Buy	+170	New	+$18.8K	﹤0.01%	8792
2021 Q1	–	Hold	0	–	–	–	8596
2018 Q2	–	Hold	0	–	-$15K	–	8016
2018 Q1	–	Hold	0	–	–	–	3655
2017 Q4	–	Hold	0	–	–	–	4029
2017 Q3	–	Hold	0	–	–	–	5211
2017 Q2	–	Hold	0	–	–	–	5798
2017 Q1	–	Hold	0	–	–	–	3316
2016 Q4	–	Hold	0	–	–	–	3590
2016 Q3	–	Hold	0	–	–	–	5097
2016 Q2	–	Hold	0	–	–	–	5500
2016 Q1	–	Hold	0	–	–	–	3610
2015 Q4	–	Hold	0	–	–	–	4334
2015 Q3	–	Hold	0	–	–	–	2116
2015 Q2	–	Hold	0	–	–	–	2574
2015 Q1	–	Hold	0	–	–	–	1886
2014 Q4	–	Hold	0	–	–	–	4343

Other funds holding NBSE

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

CMU

Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Simplex Trading's NBSE Position: Q2 2023 in Review

Simplex Trading sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q2 2023, closing a stake of 86 shares.

Simplex Trading first reported a position in NBSE in Q1 2015 and held it in 18 quarters. The position peaked at $120K in Q1 2021. 27 funds tracked by Wall St. Rank hold NBSE as of Q2 2023.

Simplex Trading reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Simplex Trading sold 86 NeuBase Therapeutics, Inc. Common Stock shares in Q2 2023.
Simplex Trading first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2015 and held it in 18 quarters.
Simplex Trading's NeuBase Therapeutics, Inc. Common Stock position peaked at $120K in Q1 2021.
27 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.